Maduro in talks with Rothchilds for help with 154 Billion debt. Maybe OCLN can shift over to Venezuela.

I think they do. Building basically a new company is not an overnight affair. So far so good although I am not a big fan of CCP,
I really like the old Chinese Culture which touches the deep soul in many around the world as seen through www.shenyun.org

Like Wray really cares. He always seems late to the show. I would bet he is heavily invested in China just like Vanguard and Blackrock.

As long as LQMT keeps picking up small accounts that is fine with me. China would be happy too as long as they keep the biggies.

Added is the Insultex which may well prove valuable where Forever Board was dropped which was probably a good idea after more DD resulting
from magnesium chloride moisture weeping reaction after some years.

Ah yes, you are right. Buck Lake Ranch the Nashville of the North as it is called.

Seems the Chinese crap where most of the problems originated due to moisture and cloride salt mixed with magnesium where the cloride is not bound well.
Magnum Board seems to have resolved the issue having UL and many other certifications.

The Chinese are famous for their dumping into western markets their low quality products.

Onward Thru The Fog. Hopefully they get this company on track.

It would be nice to see this get exciting once again.

In Tennessee near Nashville.

Let your eyes feast on these babies.
The Murex breccia zones are located in the central part of the property and are interpreted as a collapsed volcanic dome structure with shallow-dipping thrust faults cut by steeply dipping faults associated with polymetallic Cu-Ag-Au-As-Sb-Mo-Te bearing sulphide mineralization. Historic work identified a 700m X 700m area, the D Zone, along with the A Zone and E Zone, two breccia zones within a 1,200m X 3,000m area.

Figure 1. Noranda Murex Breccia Zones A-E
Figure 1. Noranda Murex Breccia Zones A-E

Noranda Surface Sampling 1987

Sample 17333 yielded 0.085% copper, 8.0 g/t silver and >100 g/t gold from a pyritic, pyrrhotitic alteration zone in a mixed lithology breccia from Zone D

Sample 17348 yielded 0.47% copper, 6.2 g/t silver, 0.14 g/t gold and 0.0026% molybdenum from a quartz veinlet in basalt with pyrite, pyrrhotite and chalcopyrite from Zone A

Sample 19012 yielded >1% copper, 18.2 g/t silver and 0.22 g/t gold from a quartz fracture filling in basalt from Zone B

Sample 19017 yielded >1% copper, 42.0 g/t silver and 1.4 g/t gold from a breccia containing pyrite, chalcopyrite and pyrrhotite from Zone B

Sample 19022 yielded >1% copper, 11.8 g/t silver and 0.22 g/t gold from a basalt fragment breccia containing pyrite, chalcopyrite & pyrrhotite from Zone B

Sample 19024 yielded >1% copper, 38.0 g/t silver and 0.24 g/t gold from gangue filled fractures in basalt from Zone B

Sample 27583 yielded >1% copper, 54.0 g/t silver and 0.12 g/t gold from an alteration zone in a pyritic diorite breccia from Zone C

Sample 27584 yielded >1% copper, 10.8 g/t silver and 0.08 g/t gold from pyrite and chalcopyrite bearing quartz veinlets in fractured basalt from Zone D

Noranda Surface Sampling 1988

Sample R-28001 yielded 1.3 g/t gold, 63 g/t silver, 5.1% copper from a select outcrop grab of massive sulphide in a basaltic breccia in Zone A

Sample R-28002 yielded 0.56 g/t gold, 26 g/t silver, 2.2% copper from a select outcrop grab of chalcopyrite vein in a basaltic breccia in Zone A

Sample R-28042 yielded 12 g/t gold, 28 g/t silver, 0.36% copper, from a select float grab of sulphidic basalt in Zone A

Sample R-28052 yielded 0.12 g/t gold, 17 g/t silver, 2.5% copper from a select matrix only outcrop grab sample from a mixed lithology breccia in Zone A

Sample R-44004 yielded 0.24 g/t gold, 27 g/t silver, 2.2% copper from a select outcrop grab sample of a fractured basalt with quartz and sulphides in Zone A

Sample R-43017 yielded 1.4 g/t gold, 17 g/t silver, 1.9% copper from a 1 m. square panel sample of sulphidic basaltic breccia in Zone A

Sample R-44028 yielded 0.74 g/t gold, 31 g/t silver, 3.8% copper from a select matrix only outcrop grab sample from a sulphidic basaltic breccia in Zone A

Sample R-27605 yielded 9.3 g/t gold, 125 g/t silver, 7.0% copper from a select outcrop grab of a sulphidic mixed lithology breccia in Zone D

Sample R-27606 yielded 6.9 g/t gold, 2.1 g/t silver, 0.23% copper from a select outcrop grab of a sulphidic mixed lithology breccia in Zone D

Sample R-28625 yielded 0.07 g/t gold, 83 g/t silver, 4.5% copper from a select outcrop grab of a sulphidic alteration zone in diorite breccia in Zone D

Sample R-28628 yielded 3.4 g/t gold, 54 g/t silver, 2.5% copper from a select outcrop grab of a sulphidic alteration zone with quartz veinlets in Zone D

Sample R-28010 yielded 4.8 g/t gold, 128 g/t silver, 5.7% copper from a select outcrop grab of a sheared, sulphidic basaltic breccia in Zone D

Sample R-28026 yielded 7.4 g/t gold, 0.5 g/t silver, 0.07% copper from a 0.27 m. chip sample from a sheared, quartz and iron oxide rich basalt in Zone D

Sample R-28089 yielded 9.0 g/t gold, 4.9 g/t silver, 0.26% copper from a select outcrop grab of a sulphidic basaltic breccia in Zone D

Sample R-28092 yielded 4.0 g/t gold, 31 g/t silver, 0.98% copper from a 0.88 m. channel sample of an altered, sulphidic shear in basalt breccia in Zone D

Sample R-28098 yielded 4.0 g/t gold, 16 g/t silver, 1.0% copper from a 0.19 m. channel sample of an altered shear zone in basalt breccia in Zone D

Sample R-28014 yielded 2.3 g/t gold, 22 g/t silver, 2.8% copper from a 0.1 m. channel sample of a sulphidic quartz vein in Zone D

Sample R-28120 yielded 5.0 g/t gold, 2.1 g/t silver, 0.13% copper from a 0.5 m. channel sample of a basaltic breccia in Zone D

Sample R-28122 yielded 10.4 g/t gold, 1.5 g/t silver, 0.13% copper from a 0.5 m. channel sample of a basaltic breccia in Zone D

Sample R-28123 yielded 4.3 g/t gold, 28 g/t silver, 1.4% copper from a 0.5 m. channel sample of a basaltic breccia in Zone D

Sample R-28124 yielded 4.4 g/t gold, 106 g/t silver, 5.9% copper from a 0.1 m. channel sample of a massive sulphide pod in a basaltic breccia in Zone D

Sample R-79784 yielded 8.5 g/t gold, 4.3 g/t silver 0.12% copper from a 5 m. chip sample of a sulphidic mixed lithology breccia in Zone D

Sample R-79797 yielded 1.1 g/t gold, 28 g/t silver, 2.8% copper from a sample of a sheared sulphidic quartz vein in basalt in Zone D

Tulameen Platinum, Magnesium, and Carbon Sequestration

Exploration at the Company’s 100% owned Tulameen Platinum Project is set to commence in the second half of April 2024. Historic assays by Imperial Metals resulted in two significant assays of 62g/t platinum and 31g/t platinum, including 4g/t gold. The property also contains a large magnesium deposit in the form of olivine and brucite, which is currently undergoing investigation for processing to magnesium oxide a widely used mineral with applications in the industrial, construction (wallboard and cement replacement), agricultural (fertilizer and animal nutrients), environmental (water treatment), and pharmaceutical (supplements) sectors. There is also great interest in the use of magnesium compounds, in particular the form of olivine and brucite, as occurs at Tulameen, for carbon sequestration. A large project is currently ongoing in Iceland, the world leader in geological carbon sequestration, utilizing magnesium compounds in situ. One tonne of olivine can bond with up to one-third of a tonne of CO2 making it one of the best natural carbon sinks. The global market for carbon sequestration price for carbon credits is in the $25 per tonne range, but this is heavily governed by local factors. The nearest carbon sequestration for British Columbia industry is out of Province in Alberta suggesting strong potential for a large scale storage facility and carbon credit creation and offset for industry in the western part of British Columbia due to the size of the deposit and potential monetization through existing carbon credit and offset programs. The Company anticipates providing further information on both the industrial magnesium compound and carbon sequestration potential of this project as developments occur. In addition, the Company will continue to focus on exploration for platinum group metals, in addition to copper, nickel and cobalt in and around the large olivine (Mg) deposit. Of note is the unique geology of the area, including, significant garnets and the historic report of a micro-diamond discovered in the southeast quadrant of the property.

Noranda and Standard Oil would never have let this property go at today's mineral prices. These are higher showings than many mines that are currently operating or anticipating operations. We ARE IN THE MIDST OF A GOLD RUSH.

Amazing how some just don't get it.

$NBRI$

Good job Jared. Keep up the good work.

in what context are you assuming this time? according to you...no thanks, I will pass.

$$CYDY$$ 2024

https://en.wikipedia.org/wiki/Leronlimab

https://en.wikipedia.org/wiki/CCR5 Yep, leronlimab. We got it. The big boys want it. There will be a deal. Bank on it.

Meanwhile, Go Sidley, Go Dr. J.

oh remember when.... now it is a reality although not with any of us. But I almost got some shares in Virgin Trains who was doing an IPO, however they pulled the plug and now it is all a private entity. Sorry retail. Seen this happen many times. Just yesterday, VAXX did same, a few years ago a graphene company sold out to a private entity in Oklahoma.

So now the choo choo is breaking ground with tons of fed money probably funneled from the Ukraine deal today that passed the Senate.
https://www.washingtontimes.com/news/2024/apr/22/all-aboard-bullet-train-las-vegas-los-angeles-may-/

How true. Likewise go to any state or federal Judicial Conduct Commission or State Bar and see how understaffed with investigators they are... oh yes, they throw the book at one or two for being a drunk and that's about it. Ever wonder why they never SunSet any State Bar? The real game has to be kept under wraps.
And going back to the SEC, just check and see who is the main attorney... she carries her maiden name but is married to a disgraced top investigative agency head.. the one who had the affair with his famous assistant. Yes, insufficient staffing where it matters, and over hiring where it makes no good sense.

Same pain being felt here as well. I have been asking for an explanation for what happened with the Forever Board. It was...is still a great product that should have taken off. They screwed up not taking full advantage of their DR Horton connection in Florida.

However, not ready to give up hope just yet. They need to focus on just one thing and do it right before jumping into the next fool idea.
Yep, tired of getting tossed a bone with no meat. So Liga, where's the beef?

These old mills are cool. Been in a few myself and assisted up Ohio Creek long ago.
"permitted since 2019, the mill has not operated and all equipment has very low hours and remains in as new working condition, including wiring, plumbing and associated fixtures including the mill building and tailings pond."

I will say, watching the separation on the shaker table is super cool especially down at the bottom where the gold and platinum spill out. Super cool.

$NBRI$

SKIPPACK, Pa., April 23, 2024 (GLOBE NEWSWIRE) -- North Bay Resources Inc. (NBRI) (the “Company” or “North Bay”) (OTC: NBRI) is pleased to announce it has completed initial powerup and testing of mill equipment at the Bishop Gold Mill (the “Mill”). Equipment tested included jaw crusher, ball mill, shaker table, and flotation tanks, as well as related conveyors and ancillary equipment. All equipment powered up successfully and is in good working order. The bushings on the ball mill will be replaced shortly to assure continuous operation. Although permitted since 2019, the mill has not operated and all equipment has very low hours and remains in as new working condition, including wiring, plumbing and associated fixtures including the mill building and tailings pond.

Mill Feedstock

The Company is in discussion and negotiations for feedstock for the Mill. The Company has targeted an initial acquisition of 10,000 tons grading one ounce per ton, approximately three months of feedstock. This equates to a total of 8,500 ounces at a projected recovery rate of 85% or $20M in gold at current spot price ($2,350 oz. Au

So guess I will throw in some more chump change. Watch as the developments keep happening. Hello

I call on Chairman Xi and LQMT to endorse this company as a token of goodwill and advancement of the free human spirit.
https://www.shenyunperformingarts.org/

Couldn't have said it better overall except to add the difficulty of navigating the political tangles especially as to China during an epoch where the future direction of the immediate struggle for power over the markets, physical assets, finances, and dominant currency hangs in balance. Given these conditions I say the company has done well to survive. Funny how bashers arrive when a company is in the midst of a turnaround.

Adding a few more of course. This will run up at some point in the near future because solid good news like the recent mill acquisition will happen again more than a few times!

Yes, I expect some interviews with Nader et al....ET AL. Going to be quite the interesting story should one ever get published.
Some who don't expect it may get an interview as well. Be ready!! FDA and bashers will follow the Nader interview most likely.
May well trigger some other investigations to dig some more and make a few adjustments. Probably going to be a lot of squirming trying to get the stories straight.

Meanwhile, Sidley takes good notes and may well have some contributions to add to the story.
So in the interim, keep up the incrimination bashers ,and oh yes, thanks for the cheapies anytime.

In the interim, Dr. Jay is slaving away. Get ready.
$CYDY$ 2024

I am 90% with you here. In my mind there is no doubt about the bad tactics of the FDA et al which has been demonstrated repeatedly over the decades. This whole NP thing merely parallels the rampant corruption within the Administrative state in general. Is this Ukraine? This isn't Ukraine... they are being played just like the investors in CytoDyn and many others who thought we had at least an agency that cared for human life. The whole ivermectin and HCQ saga demonstrated this so vividly among so many other dirty tricks that have surfaced post covid...that MSM skips around. So NP and KareemD could see from the inside how the story was going to play out. Were they both disgusted or just buddies in the fox hole together trying to survive some nasty orders? Yes, NP was paid way too much. I believe he knew the outcome as a result of and after attempting EUA for Covid. Enter big brother. Look at all those who got shot down too. Many other non-club pharmas and university scientists who could see through the charade ... as emails have disclosed. So IMO it came down to the coup taking place with 13D. Support them and lose the whole enchilada or stay on board the ship and see where it sails? Had 13D some smarts they could have been successful, but they rallied the short bashers that no one likes... a big mistake and a costly one.

So I am more furious with the FDA than ever. Sure NP and buddy sold us down the river. So what is new? Just look at the state of affairs everywhere you find a large govt agency. Rules and regulations and mission statements are a joke for those who dangle the carrots. NP liked carrots better than the mercury found in tuna or the lead found in some skulls. The Iranian conspirators Pourhassan and Hassanpour, whatever his name is, will probably be left out to dry from all accounts unless they have some more Maji to leak out. Will Darius The Great rise again? This could get real interesting as things are quite sticky.

Consequently, I don't expect much but a lot of damage control. The sugar coated version is due out. Should make an exciting end to another great chapter in the leronlimab saga.

And to remember who let the light shine out of darkness? Thank goodness for Dr. Jay. who has penetrated this darkness with a ray of bright light.

Ready for the new chapter to continue lighting the path to success? I am. $$CYDY$$ 2024

My gosh that's a bunch of strings. Who would have thunk it?

May well be most all string instruments could see some quality enhancements. That's a fairly sizeable market. Who knows, perhaps better resonance would come from wind instruments as well, especially the mouth pieces on horns.

Today from another poster who was Ihub born in 2000. "There are some individuals on this platform who have made over 700 posts about a single company and all of them are negative. This speaks volumes in itself. To all the short bashers out there, bring it on! If your stock is being bashed, take it as the ultimate compliment. Don't waste your time, just report these traders who are trying to manipulate the market and keep them where they belong."

I would venture to say we have exceeded this with some short bashers here on CYDY.

Why is this? One simple word, leronlimab. So we got it, they want it and until they get it they will pay bashers to bash so they can try to buy up the company.
Secretly they are buying shares little by little just below the threshold of moving the stock up. Accumulation on the sly by those who know the value of leronlimab which is pretty much everyone. This is how the game is being played which is why I buy on any worthwhile dip especially now after the hold was lifted with assistance from the FDA on protocol development. So we know the company is going forward and in my opinion they are being extra cautious to insure an airtight HIV protocol along with continuing basically from where it was left off. Once a new trial gets started then is when I would start contemplating a collaborative effort with another pharma . Most likely I think for another indication perhaps in the wide arena of cancer. The company has definitely made good strides in 2023 revamping. 2024 is shaping up fine with the new CEO who masterfully assisted in the back and forth FDA negotiations to rectify to their arduous demands with ending the long slug of a year plus hold on trials. Patience will pay as the data will lead the way for very nice gains. A lot more of the medical science world now knows about leronlimab. We enter a new era much more grounded and savvy as to the obstacles. Don't forget the new possibilities even outside of the new longer acting leronlimab. You can add to that whatever else the contracted artificial intelligence company discovers. Things are going to get more exciting from here on. So for me, thanks basher pigeons for the cheapies. $$CYDY$$ 2024

whaaa? I see no answer. Typical short paid basher probably, and no skin in the game. Oh well, Nice double plus made again.

Since when is some earned income a bad thing? Interesting, perhaps more on the way?!!

Not grim at all. However, here are some grim factors that have nothing to do with the basic fundamentals.
It is called a short attack by those who are threatened by the powerful potential of Leronlimab.

Date Close High Low Volume Short Volume % of Vol Shorted
Apr 15 NA NA NA 4,669,367 2,012,826 percent 43
Apr 17 NA NA NA 700,478 226,705 percent 32

Shorts come up price goes down
Shorts come down price goes up
Shorts come off, PPS skyrockets

$$CYDY$$ Home of leronlimab. We got it, they want it. That's what all the fuss is about. If it was justaSaline solution, it would be justaNada justaNofacts!!

Q4 sales up to 15 Million double last year almost. May have to dip into to this one. Looks way over sold too. Most interesting set up.

jaja no adivino maji. Guess again.

Expecting the FDA to clean up their act should there be a new sheriff in town. The medical scientist with integrity are fed up with the revolving door.
https://www.fiercepharma.com/pharma/biogen-grants-ceo-viehbacher-4m-2023-pay-after-massive-welcome-package

If they cannot persuade them logically, just flash some cash. https://www.science.org/content/article/hidden-conflicts-pharma-payments-fda-advisers-after-drug-approvals-spark-ethical

And the ultimate question.....? https://www.forbes.com/sites/johnlamattina/2022/09/22/why-is-biopharma-paying-75-of-the-fdas-drug-division-budget/?sh=1cd8cd0f7480

I find it quite amazing the investors in CytoDyn are not dissuaded in the least about the bargain prices brought to us by shorting tactics from Pig Pharma's
Pigeon Coop.

Go Dr. Jay. $$CYDY$$ 2024 Go Sidley Go. Leronlimab, we got it, some lucky company will be allowed to partner for a little piece. Expecting it.

It's not a pump. This is a bottom load with a mining in development stage pre-revenue that just bought
a gold mill. Not worried in the least that this will go up. Plus it was the CEO that eliminated the RS for the foreseeable future perhaps forever!

Got some more by the way!!

Agreed.

or for paid bashers to take a hike. that would even things out. fair is fair right?

P.S.

I will be buying more.

write or call the company if you have a complaint. Otherwise I trust the CEO who has tons of experience in running companies to know what the reg requirements would be. Better cover your shorts before the next announcement. By the way, it is not common practice to postpone a RS.

Do you want the company to succeed or not?

I bot a few more myself.

I expect you are short on stock in general. I expect you look at the history with kaleidescope glasses.
When was the forward split, when was the last RS?
When did the new CEO change his mind on the RS earlier contemplated?
When did you learn to invest in pre developmental mining operations?
Shareholders have not been fleeced by the company, they were fleeced by short bashers like Gity.
You must admit, the purchasing of a mill is quite astute and certainly certifies that the company is dead serious in this gold mining boom.

I've used it for decades. Effective and safe. Now this:
I especially like PG.

Studying the ways viruses affect cellular pathways during infection may help in developing treatments for infectious diseases such as COVID-19.
A new study, conducted by researchers at the University of Alberta and published in the npj Viruses journal, found that certain cancer treatment drugs can promote cells to secrete antiviral interferons. These drugs target the SARS-CoV-2 virus, which causes COVID-19, and are also effective against multiple pathogenic RNA viruses.
Interferons are natural proteins that bolster the body’s immune system in combating infections and diseases such as cancer. They earned their name because they interfere with viruses, stopping them from spreading.

Both COVID-19 and some cancers activate the Wnt/beta-catenin pathway—a chain reaction inside the cell. Drugs that block this pathway, originally made to treat cancer, might also help fight COVID-19.

When the Wnt/beta-catenin pathway gets activated, it slows down the production of interferons. This pathway also negatively affects the immune system.

In a study, scientists tested two drugs, KYA1797K and E7449, that block the Wnt/beta-catenin pathway. They found that these drugs reduced the amount of virus in the lungs of mice. The drug E7449 was especially good at preventing weight loss and lung damage in the infected mice.
Related Stories
One in Five Pfizer Drug Users Experience COVID-19 Rebound: Study
11/14/2023
One in Five Pfizer Drug Users Experience COVID-19 Rebound: Study
Antiviral Drug May Shorten COVID-19-Induced Loss of Taste and Smell
10/24/2023
Antiviral Drug May Shorten COVID-19-Induced Loss of Taste and Smell

Tom Hobman, a professor of cell biology at the University of Alberta’s Faculty of Medicine and Dentistry and one of the study authors, explained in a statement that after using these drugs, cells produced interferons in response to viral infections at levels four to six times higher than before. Experiments also revealed that the virus was inactivated to less than one-ten-thousandth of its original levels.
Story continues below advertisement

He pointed out that interferons prevent infected cells from producing more viruses primarily in two ways: “It shuts down the infected cell, often resulting in cell death, and it also acts on the surrounding cells to prevent them from being infected.”
The researchers also tested viruses other than COVID-19 and found that the drugs exhibit broad-spectrum activity against a variety of RNA viruses. These include coronaviruses, responsible for seasonal respiratory infections, as well as mosquito-borne viruses such as Zika and Mayaro.
Ongoing Drug Trials for COVID-19
In addition to drugs targeting the Wnt/beta-catenin pathway, other drugs are also being explored for the potential to alleviate the COVID-19 virus.
A clinical trial published in February that involved 1,821 mild to moderate COVID-19 patients indicated that a drug called ensitrelvir significantly shortened the duration of symptoms in patients with COVID-19.
A phase II to III clinical trial of the anti-COVID-19 drug Simnotrelvir involving 1,208 patients with mild to moderate COVID-19 infection was published in the New England Journal of Medicine. The results show that patients who received Simnotrelvir treatment within 72 hours of COVID-19 symptom onset had their “time to sustained resolution of symptoms” shortened by 35.8 hours. In a subgroup with risk factors for severe COVID-19, Simnotrelvir reduced the time by 60 hours.
Natural Compounds With Antiviral Activity
In addition to drugs under development, some common plants and natural compounds also possess potent antiviral activity.
1. Iota-carrageenan
Iota-carrageenan is a polysaccharide extracted from red algae, commonly used as a thickener in puddings or ice creams. A study in Argentina involving 400 hospital workers indicates that a nasal spray containing iota-carrageenan could reduce the risk of contracting COVID-19 by about 80 percent.
2. Curcumin
A clinical trial published in the journal Nutrients in 2022 found that curcumin supplementation can effectively improve symptoms such as coughing, difficulty breathing, and muscle soreness in patients with mild to severe COVID-19. Compared to the control group, oxygen saturation was significantly higher in the treatment group.
3. Platycodon grandiflorum
A study proposed that platycodin D, a compound in Platycodon grandiflorum, is a potent natural product for preventing and treating COVID-19. The study found that Platycodon grandiflorum “effectively blocks” the entry of the COVID-19 virus into cells by altering the distribution of membrane cholesterol.
4. Reishi, Perilla, and Peppermint
Cell and animal experiments have demonstrated that extracts of Reishi mushroom, Perrila, and Chinese mint exhibit efficacy in inhibiting the COVID-19 virus. A particular compound in Reishi mushroom, Ganoderma lucidum, retains its antiviral effect even when diluted 1,280 times, with no cellular damage.
5. Green Tea and Black Tea
Tea polyphenols in green tea and black tea also have broad-spectrum antiviral effects. Animal experiments have found that catechins can inhibit coronavirus replication, enhance immunity, and improve acute lung injury. There are also studies indicating that tea catechins and catechin derivatives have the ability to effectively inactivate Omicron subvariants.
By Ellen Wan, Epoch Health Japan
3/30/2024
Updated:
4/2/2024

LOL, we have a Mexican Standoff in the works. The desperados are fighting over the booty. LOL, no matter who wins, the loser will be reimbursed with tax payer money.